Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 18 and up

Adjuncts to non-surgical periodontal treatment in smokers and non-smokers with periodontitis

Official title: Clinical Efficacy of I-PRF, Povidone-Iodine and Laser as Adjuncts to Non-surgical Periodontal Treatment in Smokers and Non-Smokers Periodontitis Patients : A Split Mouth Randomized Clinical Trial

Run by Military Hospital of Tunis · NCT07707063 · Data updated 2026-11-12

This trial tests whether adding I-PRF, povidone-iodine, or diode laser to standard deep cleaning helps reduce pocket depth and improve gum health in adults with periodontitis, including smokers.

More Periodontitis trials

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment50 (estimated)
SponsorMilitary Hospital of Tunis
Academic / other
Drugs / interventionschemotherapy
Locations1 site (Tunis, Mont Fleury)
StatusRecruiting
StartedMay 25, 2026
Main results expectedMay 18, 2027
Study endsMay 18, 2027
Registry record updatedJuly 16, 2026
Trial IDNCT07707063 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with stage II–IV periodontitis who have at least one bleeding pocket greater than 4 mm in every quadrant.

Probably not a fit

Patients with contraindications to iodine or methylene blue, pregnant or lactating individuals, or those on recent antibiotics or immunosuppressants may not benefit or be eligible for this approach.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, split-mouth, controlled trial compares four subgingival adjuncts used alongside scaling and root planing for stage II–IV periodontitis. The study standardizes adjunct protocols to reduce operator variability and assess efficacy in both smokers and non-smokers. Primary outcomes include probing pocket depth reduction, bleeding on probing, and clinical attachment level gain. The hypothesis is that I-PRF will provide the greatest benefit, particularly in smokers, due to its growth factors and tissue repair effects. The investigation aims to determine which adjunct offers the most consistent improvement over saline irrigation and SRP alone.

Why it matters

Potential benefit: If successful, patients could experience faster inflammation reduction and better gum support when using these adjuncts with standard cleaning.

How similar studies have gone: Previous investigations suggest adjunctive therapies can improve periodontal outcomes, but results vary by modality and patient factors; this study extends those findings to a standardized, multi-arm, smoker-inclusive design.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion: Patients with Stage II-IV Periodontitis; at least one bleeding pocket \> 4 mm minimum in every quadrant.

Exclusion: patients who:

* Pregnant /Lactating
* History of radiotherapy or chemotherapy in the head/neck region.
* Known hypersensitivity to Iodine or Methylene blue solution
* Systematic antibiotic use within the last 30 days
* Long-term use of immunosuppressants or corticosteroids (daily use)
* type 1 / 2 diabetes

Where it's running

  • Military Hospital of Instruction of Tunis
    Tunis, Mont Fleury, Tunisia
    Recruiting

Study contacts

  • Principal investigator: hedi chouchene, DDS — Military Hospital of Instruction of Tunis
  • Study coordinator: Hela Jegham, DDS - Professor
  • Email: hela.jegham@yahoo.fr
  • Phone: +21654241521

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.